CLINICAL_TRIALS trial_result · 2019-12-30

Clinical Trial Update: A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease [Phase 2]

Phase 2 study assessing anti-inflammatory effects of solithromycin in chronic obstructive pulmonary disease was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Imperial College London | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: TERMINATED | Results posted: 2019-12-30